1672-1535
2008 Issue 1
..............page:插2
..............page:插1
..............page:插1
chao sheng zao ying ping jia gao qiang du ju jiao chao sheng zhi liao gan zhuan yi ai liao xiao 1 li
li li xia ; huang xue qin ; zhang wei min ; zhu xian sheng
li li xia ; huang xue qin ; zhang wei min ; zhu xian sheng
..............page:99-100
wu yong en du zhi liao e xing zhong liu de lin chuang guan cha
huang kai rong ; fang xiang yang ; tan jin long ; luo hong ; he zhao hong ; zhan dong zi ; fang li jun ; liu ye hua
huang kai rong ; fang xiang yang ; tan jin long ; luo hong ; he zhao hong ; zhan dong zi ; fang li jun ; liu ye hua
..............page:96-98
Expression of KAI1/CD82 and intergrin α3β1 proteins in endometrial adenocarcinoma and its clinical significance
Zhu Ting;Li Qun
Zhu Ting;Li Qun
..............page:91-95
Expression of survivin in breast carcinomas and its significance
Wang Faliang;Bo Aihua;Qi xiaoli;Lu Guangping;Hou Jinchao
Wang Faliang;Bo Aihua;Qi xiaoli;Lu Guangping;Hou Jinchao
..............page:87-90
Clinical analysis of the outcome of papillary renal cell carcinoma
Shou Jianzhong;Ma Jianhui;Xiao Zhendong;Xiao Zejun;Tian Jun;Wang Dong;Bi Xingang;Li Changling
Shou Jianzhong;Ma Jianhui;Xiao Zhendong;Xiao Zejun;Tian Jun;Wang Dong;Bi Xingang;Li Changling
..............page:83-86,90
Molecular mechanisms of drug resistance in colorectal cancer
Ran Feiwu;Zhang Honggang
Ran Feiwu;Zhang Honggang
..............page:77-82
The andvances of tumor anti- angiogenetic therapy
Li Yong;Sun Yan;Zhang Xiangru
Li Yong;Sun Yan;Zhang Xiangru
..............page:65-76
Taxol resistance in ovarian cancer and its management
Li Ning;Li Nan;Wu Lingying
Li Ning;Li Nan;Wu Lingying
..............page:58-64,90
Sentinel lymph node identification in early vulvar cancer
Zhang Gongyi;Li Bin
Zhang Gongyi;Li Bin
..............page:53-57
Progression in osteosarcoma under medical treatment:Highlights in ASCO 2007
Lin Lizhu;Liu Qinghua;Zhou Daihan
Lin Lizhu;Liu Qinghua;Zhou Daihan
..............page:47-52
tao xi bao lin ba liu zhi liao jin zhan
huang zhi zuo ; fan yun
huang zhi zuo ; fan yun
..............page:41-46
Application and prospect of functional imaging on defining biological target volume in non-small cell lung cancer
Wu Huita;Chen Yuan;Wu Zhijian
Wu Huita;Chen Yuan;Wu Zhijian
..............page:36-40
Progress in non-surgical treatment of esophageal carcinoma
Sun Suping;Yang Hongpeng;Li Gong
Sun Suping;Yang Hongpeng;Li Gong
..............page:30-35,52
Molecularly targeted therapy for pancreatic cancer
Guo Chunguang;Zhao Ping
Guo Chunguang;Zhao Ping
..............page:24-29
The application of clodronate in cancer
Chen Shanshan;Feng Fengyi
Chen Shanshan;Feng Fengyi
..............page:21-23
Effectiveness and Safety of pamidronafe and zoledronic acid in metastatic bone diseases
Qin Yan;Feng Fenyi
Qin Yan;Feng Fenyi
..............page:16-20,29
Clinical evaluation of ibandronate in treatment of tumorous bone metastasis
Xing Puyuan;Feng Fengyi
Xing Puyuan;Feng Fengyi
..............page:11-15
Clinical application of bisphosphonates in treatment of bone metastases
Dong Mei;Feng Fengyi
Dong Mei;Feng Fengyi
..............page:6-10,15
..............page:4-5
..............page:2-3
xin nian ji yu
zhao ping
zhao ping
..............page:1